15 devices · GMDN 60441
Newborn metabolic screening controls are specialized materials used to verify the performance and accuracy of diagnostic assays. These products ensure that laboratory tests correctly identify potential congenital or metabolic disorders in infants using dried blood spot specimens.
These control materials are designed to simulate clinical samples to validate the detection of various analytes, such as hormones, enzymes, or amino acids. Users should note that these products are intended for quality assurance purposes to confirm that screening systems are functioning within expected parameters.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.